Upstream signalling of mTORC1 and its hyperactivation in type 2 diabetes (T2D)

키워드

참고문헌 (104)

1. Workman JJ, "Environmental signaling through the mechanistic target of rapamycin complex 1 mTORC1 goes nuclear", Cell Cycle, 13, pp.714~725 (2014)
2. Dalle Pezze P, "A dynamic network model of mTOR signaling reveals TSC-independent mTORC2 regulation", Sci Signal, 5, pp.ra25~ (2012)
3. Cybulski N, "TOR complex 2: a signaling pathway of its own", Trends in Biochemical Sciences, 34, pp.620~627 (2009)
4. Kim DH, "mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery", Cell, 110, pp.163~175 (2002)
5. Linares JF, "K63 polyubiquitination and activation of mTOR by the p62-TRAF6 complex in nutrient-activated cells", Mol Cell, 51, pp.283~296 (2013)
6. Duran A, "p62 is a key regulator of nutrient sensing in the mTORC1 pathway", Mol Cell, 44, pp.134~146 (2011)
7. Laplante M, "mTOR signaling in growth control and disease", Cell, 149, pp.274~293 (2012)
8. Laplante M, "mTOR signaling at a glance", J Cell Sci, 122, pp.3589~3594 (2009)
9. Avila-Flores A, "Modulation of the mammalian target of rapamycin pathway by diacylglycerol kinase-produced phosphatidic acid", J Biol Chem, 280, pp.10091~10099 (2005)
10. Zoncu R, "mTOR: from growth signal integration to cancer, diabetes and ageing", Nat Rev Mol Cell Biol, 12, pp.21~35 (2011)
11. Ali M, "Telomerase reverse transcriptase induces basal and amino acid starvation-induced autophagy through mTORC1", Biochem Biophys Res Commun, 478, pp.1198~1204 (2016)
12. Cheng H, "Telomerase deficiency delays renal recovery in mice after ischemia-reperfusion injury by impairing autophagy", Kidney Int, 88, pp.85~94 (2015)
13. Um SH, "Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1", Cell Metab, 3, pp.393~402 (2006)
14. Taylor PM, "Role of amino acid transporters in amino acid sensing", Am J Clin Nutr, 99, pp.223S~230S (2014)
15. Jewell JL, "Amino acid signalling upstream of mTOR", Nat Rev Mol Cell Biol, 14, pp.133~139 (2013)
16. Jia GH, "Overnutrition, mTOR signaling, and cardiovascular diseases", Am J Physiol Regul Integr Comp Physiol, 307, pp.R1198~R1206 (2014)
17. Greider CW, "Regulating telomere length from the inside out: the replication fork model", Gene Dev, 30, pp.1483~1491 (2016)
18. Sahin E, "Telomere dysfunction induces metabolic and mitochondrial compromise", Nature, 470, pp.359~ (2011)
19. Kuhlow D, "Telomerase deficiency impairs glucose metabolism and insulin secretion", Aging (Albany NY), 2, pp.650~ (2010)
20. Lynch CJ, "Role of leucine in the regulation of mTOR by amino acids: Revelations from structure-activity studies", J Nutr, 131, pp.861s~865s (2001)
21. Wolfson RL, "Sestrin2 is a leucine sensor for the mTORC1 pathway", Science, 351, pp.43~48 (2016)
22. Jewell JL, "Differential regulation of mTORC1 by leucine and glutamine", Science, 347, pp.194~198 (2015)
23. Sancak Y, "The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1", Science, 320, pp.1496~1501 (2008)
24. Kim E, "Regulation of TORC1 by Rag GTPases in nutrient response", Nat Cell Biol, 10, pp.935~945 (2008)
25. Chantranupong L, "The Sestrins interact with GATOR2 to negatively regulate the amino-acid-sensing pathway upstream of mTORC1", Cell Rep, 9, pp.1~8 (2014)
26. Parmigiani A, "Sestrins inhibit mTORC1 kinase activation through the GATOR complex", Cell Rep, 9, pp.1281~1291 (2014)
27. Wang S, "Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1", Science, 347, pp.188~194 (2015)
28. Floyd S, "The insulin-like growth Factor-I-mTOR signaling pathway induces the mitochondrial pyrimidine nucleotide carrier to promote cell growth", Mol Biol Cell, 18, pp.3545~3555 (2007)
29. Hinault C, "Amino acids and leucine allow insulin activation of the PKB", mTOR pathway in normal adipocytes treated with wortmannin and in adipocytes from db, FASEB J, pp.2004, 18[DOI]
30. Dibble CC, "Signal integration by mTORC1 coordinates nutrient input with biosynthetic output", Nat Cell Biol, 15, pp.555~564 (2013)
31. Inoki K, "TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling", Nat Cell Biol, 4, pp.648~657 (2002)
32. Inoki K, "Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling", Gene Dev, 17, pp.1829~1834 (2003)
33. Catania C, "mTORC1 signaling in energy balance and metabolic disease", Int J Obes (Lond.), 35, pp.751~761 (2011)
34. Nakashima RA, "Contributions of glycolysis and oxidative phosphorylation to adenosine 5’-triphosphate production in AS-30D hepatoma cells", Cancer Res, 44, pp.5702~5706 (1984)
35. Vander Heiden MG, "Understanding the Warburg effect: the metabolic requirements of cell proliferation", Science, 324, pp.1029~1033 (2009)
36. Bartlett K, "Mitochondrial ‐oxidation", Eur J Biochem, 271, pp.462~469 (2004)
37. Sato R, "Replacement of serine-871 of hamster 3-hydroxy-3-methylglutaryl-coa reductase prevents phosphorylation by AMP-activated kinase and blocks inhibition of sterol synthesis induced by ATP depletion", Proc Natl Acad Sci U S A, 90, pp.9261~9265 (1993)
38. Inoki K, "TSC2 mediates cellular energy response to control cell growth and survival", Cell, 115, pp.577~590 (2003)
39. Gwinn DM, "AMPK phosphorylation of raptor mediates a metabolic checkpoint", Mol Cell, 30, pp.214~226 (2008)
40. Sengupta S, "mTORC1 controls fasting-induced ketogenesis and its modulation by ageing", Nature, 468, pp.1100~1104 (2010)
41. Zielinski DC, "Systems biology analysis of drivers underlying hallmarks of cancer cell metabolism", Sci Rep, 7, pp.41241~ (2017)
42. Towler MC, "AMP-activated protein kinase in metabolic control and insulin signaling", Circ Res, 100, pp.328~341 (2007)
43. Kim J, "AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1", Nat Cell Biol, 13, pp.132~141 (2011)
44. Hardwick JP, "Eicosanoids in metabolic syndrome", Adv Pharmacol, 66, pp.157~266 (2013)
45. Kerner J, "Fatty acid import into mitochondria", Biochim Biophys Acta, 1486, pp.1~17 (2000)
46. Nojima H, "The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates, p70 S6 kinase and 4E-BP1, through their TOR signaling (TOS) motif", J Biol Chem, 278, pp.15461~15464 (2003)
47. Roberts DJ, "Hexokinase-II positively regulates glucose starvation-induced autophagy through TORC1 inhibition", Mol Cell, 53, pp.521~533 (2014)
48. Feng Z, "The coordinate regulation of the p53 and mTOR pathways in cells", Proc Natl Acad Sci U S A, 102, pp.8204~8209 (2005)
49. Bukhari SA, "Serum haematological and biochemical indices of oxidative stress and their relationship with DNA damage and homocysteine in Pakistani type II diabetic patients", Pak J Pharm Sci, 28, pp.881~889 (2015)
50. Association AD, "Diagnosis and classification of diabetes mellitus", Diabetes care, 33, pp.S62~S69 (2010)
51. Billington CJ, "Overweight, obesity, and health risk", Arch Intern Med, 160, pp.898~904 (2000)
52. Völkers M, "PRAS40 prevents development of diabetic cardiomyopathy and improves hepatic insulin sensitivity in obesity", Embo Mol Med, 6, pp.57~65 (2014)
53. Samuel VT, "Mechanisms for insulin resistance: common threads and missing links", Cell, 148, pp.852~871 (2012)
54. Han J, "The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1", Nature, 524, pp.243~246 (2015)
55. Cornu M, "Hepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21", Proc Natl Acad Sci U S A, 111, pp.11592~11599 (2014)
56. Passtoors WM, "Gene expression analysis of mTOR pathway: association with human longevity", Aging Cell, 12, pp.24~31 (2013)
57. Engelman JA, "The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism", Nat Rev Genet, 7, pp.606~619 (2006)
58. Chalhoub N, "PTEN and the PI3-kinase pathway in cancer", Annu Rev Pathol, 4, pp.127~150 (2009)
59. Um SH, "Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity", Nature, 431, pp.200~205 (2004)
60. Thedieck K, "Inhibition of mTORC1 by astrin and stress granules prevents apoptosis in cancer cells", Cell, 154, pp.859~874 (2013)
61. Melnik BC, "The impact of cow's milk-mediated mTORC1- signaling in the initiation and progression of prostate cancer", Nutr Metab, 9, pp.74~ (2012)
62. Chang L, "Insulin signaling and the regulation of glucose transport", Mol Med, 10, pp.65~71 (2004)
63. Uno K, "A hepatic amino acid", mTOR, Nat Commun, pp.2015, 6[DOI]
64. Tremblay F, "Role of dietary proteins and amino acids in the pathogenesis of insulin resistance", Annu Rev Nutr, 27, pp.293~310 (2007)
65. Zoncu R, "mTOR : from growth signal integration to cancer, diabetes and ageing", Nat Rev Mol Cell Biol, 12, pp.21~35 (2011)
66. Laplante M, "mTORC1 activates SREBP-1c and uncouples lipogenesis from gluconeogenesis", Proc Natl Acad Sci U S A, 107, pp.3281~3282 (2010)
67. Yecies JL, "Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways", Cell Metab, 14, pp.21~32 (2011)
68. Kumashiro N, "Targeting pyruvate carboxylase reduces gluconeogenesis and adiposity and improves insulin resistance", Diabetes, 62, pp.2183~2194 (2013)
69. Song SM, "Mechanism of fat-induced hepatic gluconeogenesis: effect of metformin", Am J Physiol-Endoc M, 281, pp.E275~E282 (2001)
70. Ginsberg HN, "Insulin resistance and cardiovascular disease", J Clin Invest, 106, pp.453~458 (2000)
71. Shimomura I, "Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob", ob mice, 2000, pp.6, 77~86
72. Jin ES, "Influence of liver triglycerides on suppression of glucose production by insulin in men", J Clin Endocr Metab, 100, pp.235~243 (2015)
73. Seppala-Lindroos A, "Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men", J Clin Endocr Metab, 87, pp.3023~3028 (2002)
74. Munoz P, "XPF nuclease-dependent telomere loss and increased DNA damage in mice overexpressing TRF2 result in premature aging and cancer", Nat Genet, 37, pp.1063~1071 (2005)
75. Steinert S, "Modification of subtelomeric DNA", Mol Cell Biol, 24, pp.4571~4580 (2004)
76. Nettleton JA, "Dietary patterns, food groups, and telomere length in the Multi-Ethnic Study of Atherosclerosis (MESA)", Am J Clin Nutr, 88, pp.1405~1412 (2008)
77. Mirabello L, "The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer", Aging Cell, 8, pp.405~413 (2009)
78. Knoops KT, "Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project", JAMA, 292, pp.1433~1439 (2004)
79. Ornish D, "Increased telomerase activity and comprehensive lifestyle changes: a pilot study", Lancet Oncol, 9, pp.1048~1057 (2008)
80. von Zglinicki T, "Oxidative stress shortens telomeres", Trends Biochem Sci, 27, pp.339~344 (2002)
81. Rode L, "Increased body mass index, elevated C-reactive protein, and short telomere length", J Clin Endocrinol Metab, 99, pp.E1671~E1675 (2014)
82. Jeanclos E, "Shortened telomere length in white blood cells of patients with IDDM", Diabetes, 47, pp.482~486 (1998)
83. Ma D, "Association between oxidative stress and telomere length in Type 1 and Type 2 diabetic patients", J Endocrinol Invest, 36, pp.1032~1037 (2013)
84. Geraldes P, "Activation of protein kinase C isoforms and its impact on diabetic complications", Circ Res, 106, pp.1319~1331 (2010)
85. Guo N, "Short telomeres compromise -cell signaling and survival", PLoS One, 6, pp.e17858~ (2011)
86. Minamino T, "A crucial role for adipose tissue p53 in the regulation of insulin resistance", Nat Med, 15, pp.1082~1087 (2009)
87. Berg CE, "Rapamycin partially prevents insulin resistance induced by chronic insulin treatment", Biophy Res Commun, 293, pp.1021~1027 (2002)
88. Stallone G, "Management of side effects of sirolimus therapy", Transplantation, 87, pp.S23~S26 (2009)
89. Cruzado JM, "Nonimmunosuppressive effects of mammalian target of rapamycin inhibitors", Transplant Rev, 22, pp.73~81 (2008)
90. Morrisett JD, "Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients", J Lipid Res, 43, pp.1170~1180 (2002)
91. Houde VP, "Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue", Diabetes, 59, pp.1338~1348 (2010)
92. Fraenkel M, "mTOR inhibition by rapamycin prevents -cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes", Diabetes, 57, pp.945~957 (2008)
93. Sundin T, "Disruption of an hTERT-mTOR-RAPTOR protein complex by a phytochemical perillyl alcohol and rapamycin", Mol Cell Biochem, 375, pp.97~104 (2013)
94. Kawauchi K, "IL-2 increases human telomerase reverse transcriptase activity transcriptionally and posttranslationally through phosphatidylinositol 3'-kinase", Akt, heat shock protein 90, and mammalian target of rapamycin in transformed NK cells, 2005, pp.174, 5261~5269
95. Guertin DA, "Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKC alpha but not S6K1", Dev Cell, 11, pp.859~871 (2006)
96. Schalm SS, "Identification of a conserved motif required for mTOR signaling", Curr Biol, 12, pp.632~639 (2002)
97. Linares JF, "K63 polyubiquitination and activation of mTOR by the p62-TRAF6 complex in nutrient-activated cells", Mol Cell, 51, pp.283~296 (2013)
98. Rosner M, "mTOR phosphorylated at S2448 binds to raptor and rictor", Amino Acids, 38, pp.223~228 (2010)
99. Wrighton KH, "Cell signalling: Where the mTOR action is", Nat Rev Mol Cell Biol, 14, pp.191~ (2013)
100. Shimobayashi M, "Making new contacts: the mTOR network in metabolism and signalling crosstalk", Nat Rev Mol Cell Biol, 15, pp.155~162 (2014)
101. Peterson TR, "DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival", Cell, 137, pp.873~886 (2009)
102. Sancak Y, "PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase", Mol Cell, 25, pp.903~915 (2007)
103. Long X, "Rheb binds and regulates the mTOR kinase", Curr Biol, 15, pp.702~713 (2005)
104. Ohji G, "Suppression of the mTOR-raptor signaling pathway by the inhibitor of heat shock protein 90 geldanamycin", J Biochem, 139, pp.129~135 (2006)

관련 논문AI추천